Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
2015 · Nature Communications · 298 citations
https://doi.org/10.1038/ncomms7169
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
369
Citations
4
h-index
4
i10-index
Nilesh Brijwani is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics & Colorectal Cancer Treatments and Studies. The author has an h-index of 4, co-authored 12 publications.
https://doi.org/10.1038/ncomms7169
https://doi.org/10.1038/s41598-017-01566-x
Click to start Chat